Chemoinformaics analysis of 1’- hydroxychavicol
| Molecular Weight | 192.214 | nRot | 3 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 8 |
| Exact Molecular Weight | 192.079 | nRing | 1 |
| Solubility: LogS | -2.058 | nHRing | 0 |
| Solubility: LogP | 1.257 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.7775 |
| nHD | 1 | BPOL | 14.6425 |
| QED | 0.451 |
| Synth | 2.635 |
| Natural Product Likeliness | 1.021 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.011 |
| CACO-2 | -4.374 |
| MDCK | 0.0000246 |
| BBB | 0.969 |
| PPB | 0.60757 |
| VDSS | 0.359 |
| FU | 0.390361 |
| CYP1A2-inh | 0.117 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.188 |
| CYP2c19-sub | 0.575 |
| CYP2c9-inh | 0.078 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.751 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.368 |
| CL | 2.084 |
| T12 | 0.678 |
| hERG | 0.029 |
| Ames | 0.105 |
| ROA | 0.198 |
| SkinSen | 0.118 |
| Carcinogencity | 0.513 |
| EI | 0.618 |
| Respiratory | 0.244 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.709697 |